CN101434591B - 一种丹参丹酚酸b的制备方法和检测方法 - Google Patents
一种丹参丹酚酸b的制备方法和检测方法 Download PDFInfo
- Publication number
- CN101434591B CN101434591B CN2007101773187A CN200710177318A CN101434591B CN 101434591 B CN101434591 B CN 101434591B CN 2007101773187 A CN2007101773187 A CN 2007101773187A CN 200710177318 A CN200710177318 A CN 200710177318A CN 101434591 B CN101434591 B CN 101434591B
- Authority
- CN
- China
- Prior art keywords
- salvianolic acid
- salvia miltiorrhiza
- ethanol
- ratio
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- SNKFFCBZYFGCQN-UHFFFAOYSA-N 2-[3-[3-[1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]carbonyl-2-(3,4-dihydroxyphenyl)-7-hydroxy-2,3-dihydro-1-benzofuran-4-yl]prop-2-enoyloxy]-3-(3,4-dihydroxyphenyl)propanoic acid Chemical compound C=1C=C(O)C=2OC(C=3C=C(O)C(O)=CC=3)C(C(=O)OC(CC=3C=C(O)C(O)=CC=3)C(O)=O)C=2C=1C=CC(=O)OC(C(=O)O)CC1=CC=C(O)C(O)=C1 SNKFFCBZYFGCQN-UHFFFAOYSA-N 0.000 title claims abstract description 91
- SNKFFCBZYFGCQN-VWUOOIFGSA-N Lithospermic acid B Natural products C([C@H](C(=O)O)OC(=O)\C=C\C=1C=2[C@H](C(=O)O[C@H](CC=3C=C(O)C(O)=CC=3)C(O)=O)[C@H](OC=2C(O)=CC=1)C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 SNKFFCBZYFGCQN-VWUOOIFGSA-N 0.000 title claims abstract description 91
- STCJJTBMWHMRCD-UHFFFAOYSA-N salvianolic acid B Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=O)C=Cc2cc(O)c(O)c3OC(C(C(=O)OC(Cc4ccc(O)c(O)c4)C(=O)O)c23)c5ccc(O)c(O)c5 STCJJTBMWHMRCD-UHFFFAOYSA-N 0.000 title claims abstract description 91
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 title claims abstract description 80
- 238000002360 preparation method Methods 0.000 title claims abstract description 28
- 241000304195 Salvia miltiorrhiza Species 0.000 title claims abstract 11
- 238000001514 detection method Methods 0.000 title description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 213
- 238000000605 extraction Methods 0.000 claims abstract description 39
- 239000011347 resin Substances 0.000 claims abstract description 38
- 229920005989 resin Polymers 0.000 claims abstract description 38
- 238000004458 analytical method Methods 0.000 claims abstract description 20
- 239000003960 organic solvent Substances 0.000 claims abstract description 18
- 230000000274 adsorptive effect Effects 0.000 claims abstract description 14
- 238000000638 solvent extraction Methods 0.000 claims abstract description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 48
- 238000010828 elution Methods 0.000 claims description 43
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 36
- 239000012141 concentrate Substances 0.000 claims description 27
- 239000006228 supernatant Substances 0.000 claims description 26
- 238000005406 washing Methods 0.000 claims description 26
- 240000007164 Salvia officinalis Species 0.000 claims description 24
- 239000007788 liquid Substances 0.000 claims description 19
- 235000017276 Salvia Nutrition 0.000 claims description 17
- 238000002474 experimental method Methods 0.000 claims description 17
- 150000001408 amides Chemical class 0.000 claims description 16
- 239000012071 phase Substances 0.000 claims description 14
- 238000001179 sorption measurement Methods 0.000 claims description 14
- 239000000706 filtrate Substances 0.000 claims description 13
- 230000001105 regulatory effect Effects 0.000 claims description 13
- 238000001291 vacuum drying Methods 0.000 claims description 13
- 239000012074 organic phase Substances 0.000 claims description 12
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 claims description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 6
- 239000013558 reference substance Substances 0.000 claims description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- YKYONYBAUNKHLG-UHFFFAOYSA-N n-Propyl acetate Natural products CCCOC(C)=O YKYONYBAUNKHLG-UHFFFAOYSA-N 0.000 claims description 4
- 229940090181 propyl acetate Drugs 0.000 claims description 4
- 238000012360 testing method Methods 0.000 claims description 4
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 2
- 229940022663 acetate Drugs 0.000 claims description 2
- 238000003556 assay Methods 0.000 claims description 2
- 229940043232 butyl acetate Drugs 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 2
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 claims description 2
- 239000000377 silicon dioxide Substances 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 45
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 238000000746 purification Methods 0.000 abstract description 2
- 238000007689 inspection Methods 0.000 abstract 3
- 239000004952 Polyamide Substances 0.000 abstract 1
- 229920002647 polyamide Polymers 0.000 abstract 1
- 244000132619 red sage Species 0.000 description 69
- 239000002253 acid Substances 0.000 description 11
- 238000002347 injection Methods 0.000 description 8
- 239000007924 injection Substances 0.000 description 8
- 229940126680 traditional chinese medicines Drugs 0.000 description 8
- 235000005412 red sage Nutrition 0.000 description 7
- YMGFTDKNIWPMGF-QHCPKHFHSA-N Salvianolic acid A Natural products OC(=O)[C@H](Cc1ccc(O)c(O)c1)OC(=O)C=Cc2ccc(O)c(O)c2C=Cc3ccc(O)c(O)c3 YMGFTDKNIWPMGF-QHCPKHFHSA-N 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 229930183842 salvianolic acid Natural products 0.000 description 5
- YMGFTDKNIWPMGF-UCPJVGPRSA-N Salvianolic acid A Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C(=C(O)C(O)=CC=1)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 YMGFTDKNIWPMGF-UCPJVGPRSA-N 0.000 description 4
- 239000003463 adsorbent Substances 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 239000003978 infusion fluid Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000008188 pellet Substances 0.000 description 4
- 239000006187 pill Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000007901 soft capsule Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- 241000700159 Rattus Species 0.000 description 3
- AIGAZQPHXLWMOJ-UHFFFAOYSA-N Tanshinone I Chemical compound C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 AIGAZQPHXLWMOJ-UHFFFAOYSA-N 0.000 description 3
- 238000009833 condensation Methods 0.000 description 3
- 230000005494 condensation Effects 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 238000003810 ethyl acetate extraction Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- -1 tanshinone compound Chemical class 0.000 description 3
- DOUMFZQKYFQNTF-WUTVXBCWSA-N (R)-rosmarinic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-WUTVXBCWSA-N 0.000 description 2
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010019668 Hepatic fibrosis Diseases 0.000 description 2
- 206010063837 Reperfusion injury Diseases 0.000 description 2
- 229930183118 Tanshinone Natural products 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 229930004069 diterpene Natural products 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 208000005069 pulmonary fibrosis Diseases 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- UJZQBMQZMKFSRV-RGKBJLTCSA-N (2s,3s)-4-[(e)-3-[(1r)-1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]-3-oxoprop-1-enyl]-2-(3,4-dihydroxyphenyl)-7-hydroxy-2,3-dihydro-1-benzofuran-3-carboxylic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=2[C@H](C(O)=O)[C@H](OC=2C(O)=CC=1)C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 UJZQBMQZMKFSRV-RGKBJLTCSA-N 0.000 description 1
- YMGFTDKNIWPMGF-AGYDPFETSA-N 3-(3,4-dihydroxyphenyl)-2-[(e)-3-[2-[(e)-2-(3,4-dihydroxyphenyl)ethenyl]-3,4-dihydroxyphenyl]prop-2-enoyl]oxypropanoic acid Chemical compound C=1C=C(O)C(O)=C(\C=C\C=2C=C(O)C(O)=CC=2)C=1/C=C/C(=O)OC(C(=O)O)CC1=CC=C(O)C(O)=C1 YMGFTDKNIWPMGF-AGYDPFETSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010008089 Cerebral artery occlusion Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- ZZAFFYPNLYCDEP-HNNXBMFYSA-N Rosmarinsaeure Natural products OC(=O)[C@H](Cc1cccc(O)c1O)OC(=O)C=Cc2ccc(O)c(O)c2 ZZAFFYPNLYCDEP-HNNXBMFYSA-N 0.000 description 1
- GCJWPRRNLSHTRY-UHFFFAOYSA-N Salvianolic acid C Natural products C=1C=C(O)C=2OC(C=3C=C(O)C(O)=CC=3)=CC=2C=1C=CC(=O)OC(C(=O)O)CC1=CC=C(O)C(O)=C1 GCJWPRRNLSHTRY-UHFFFAOYSA-N 0.000 description 1
- GCJWPRRNLSHTRY-VURDRKPISA-N Salvianolic acid C Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=2C=C(OC=2C(O)=CC=1)C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 GCJWPRRNLSHTRY-VURDRKPISA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 238000005906 dihydroxylation reaction Methods 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 125000000567 diterpene group Chemical group 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 230000007074 memory dysfunction Effects 0.000 description 1
- 201000007309 middle cerebral artery infarction Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- DOUMFZQKYFQNTF-MRXNPFEDSA-N rosemarinic acid Natural products C([C@H](C(=O)O)OC(=O)C=CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-MRXNPFEDSA-N 0.000 description 1
- TVHVQJFBWRLYOD-UHFFFAOYSA-N rosmarinic acid Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=Cc2ccc(O)c(O)c2)C=O TVHVQJFBWRLYOD-UHFFFAOYSA-N 0.000 description 1
- PRYXPGFZVGZNBL-ADLFWFRXSA-N salviol Chemical compound CC(C)c1cc2CC[C@H]3C(C)(C)C[C@H](O)C[C@]3(C)c2cc1O PRYXPGFZVGZNBL-ADLFWFRXSA-N 0.000 description 1
- AJSGWTLZEUBGFV-UHFFFAOYSA-N salviol Natural products CC(C)c1cc2CCC3C(CC(O)CC3(C)C)c2cc1O AJSGWTLZEUBGFV-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
组别 | 丹参丹酚酸B含量% | 丹参丹酚酸B保留时间min |
12345678910111213141516171819 | 90.0197.195.999.894.998.394.994.296.397.095.391.999.196.496.993.294.995.293.9 | 41.841.241.541.941.741.042.041.741.441.941.341.841.741.141.341.140.941.341.9 |
20 | 92.7 | 42.0 |
组别 | 检测批次 | 丹参丹酚酸B平均含量 |
方案1方案2方案3 | 555 | 74.271.782.9 |
方案4 | 10 | 97.1 |
组别 | 检测批次 | 丹参丹酚酸B平均含量 |
方案1方案2方案3 | 555 | 91.790.392.7 |
方案4 | 10 | 99.9 |
组别 | 丹参药材的重量kg | 丹参丹酚酸B提取物重量g | 丹参丹酚酸B含量% | 提取率% |
方案1方案2方案3 | 111 | 9.78.910.3 | 74.772.083.1 | 0.730.640.86 |
方案4 | 1 | 31.7 | 96.9 | 3.07 |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101773187A CN101434591B (zh) | 2007-11-14 | 2007-11-14 | 一种丹参丹酚酸b的制备方法和检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101773187A CN101434591B (zh) | 2007-11-14 | 2007-11-14 | 一种丹参丹酚酸b的制备方法和检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101434591A CN101434591A (zh) | 2009-05-20 |
CN101434591B true CN101434591B (zh) | 2012-11-14 |
Family
ID=40709243
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007101773187A Expired - Fee Related CN101434591B (zh) | 2007-11-14 | 2007-11-14 | 一种丹参丹酚酸b的制备方法和检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101434591B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115969900A (zh) * | 2022-12-23 | 2023-04-18 | 贵州威利德制药有限公司 | 一种丹参膏药物的制备及其检测方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1876641A (zh) * | 2006-07-13 | 2006-12-13 | 大连理工大学 | 一种提取纯化丹酚酸b的方法 |
CN1981809A (zh) * | 2005-12-14 | 2007-06-20 | 天津天士力现代中药研究开发有限公司 | 一种丹参有效组分、制剂及其制备方法与用途 |
-
2007
- 2007-11-14 CN CN2007101773187A patent/CN101434591B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1981809A (zh) * | 2005-12-14 | 2007-06-20 | 天津天士力现代中药研究开发有限公司 | 一种丹参有效组分、制剂及其制备方法与用途 |
CN1876641A (zh) * | 2006-07-13 | 2006-12-13 | 大连理工大学 | 一种提取纯化丹酚酸b的方法 |
Non-Patent Citations (1)
Title |
---|
陈世敏等.丹酚酸B提取工艺的研究.《中草药》.2007,第30卷(第4期),第477-479页. * |
Also Published As
Publication number | Publication date |
---|---|
CN101434591A (zh) | 2009-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101709059B (zh) | 五味子单体成分的分离制备方法 | |
CN102976909B (zh) | 一种从生姜中提取纯化6-姜酚的方法 | |
CN100497365C (zh) | 一种山茱萸环烯醚萜苷类提取物同时提取及检测方法 | |
CN103819445B (zh) | 小叶莲中两个具有降血脂活性的新异戊烯基化黄酮类化合物的制备方法 | |
CN105859803B (zh) | 一种没食子酰基葡萄糖的制备方法 | |
CN108802255A (zh) | 测定复方制剂中灵芝酸a和灵芝三萜类成分含量的方法 | |
CN107510710A (zh) | 一种从甘草残渣中富集2型糖尿病靶点抑制剂的方法和医药用途 | |
Dang et al. | Target separation of flavonoids from Saxifraga tangutica using two‐dimensional hydrophilic interaction chromatography/reversed‐phase liquid chromatography | |
CN1289470C (zh) | 白花败酱草中几种高纯度药用物质的快速制备方法 | |
CN102219685B (zh) | 一种丹参丹酚酸a的制备方法 | |
CN104447910A (zh) | 从中药山茱萸中制备马钱苷的方法 | |
CN101810696B (zh) | 一种苹果总三萜的制备方法及用该方法制备的苹果总三萜 | |
CN106496292A (zh) | 一种从栀子中同时制备6个环烯醚萜苷类成分的方法 | |
CN102688261A (zh) | 一种凤尾草提取物及其制备方法和用途 | |
CN101434591B (zh) | 一种丹参丹酚酸b的制备方法和检测方法 | |
CN102070683A (zh) | 同时制备parishin、parishin B、parishin C化学对照品的方法 | |
CN102464586B (zh) | 一种丹酚酸a的制备方法 | |
CN103145729B (zh) | 银杏内酯b化合物及其制备方法 | |
CN102702289A (zh) | 应用高速逆流色谱法从大叶白麻中纯化三种黄酮苷的方法 | |
CN105906687B (zh) | 一种从丹参中分离纯化多种丹参酮单体成分的方法 | |
Cui et al. | Trace anti-inflammatory β-carboline alkaloid identified in Arenaria kansuensis by two-dimensional chromatography coupled with UniElut C18AEX based solid-phase extraction re-enrichment technology | |
CN103479723A (zh) | 丹参二萜醌有效部位及其逆流色谱制备方法和癌症治疗应用 | |
CN107721857A (zh) | 一种从平卧菊三七中制备高纯度绿原酸的方法 | |
CN102093210A (zh) | 6种银杏酸单体的纯化制备方法 | |
CN103044253A (zh) | 一种藏丹参中迷迭香酸的提取分离方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
DD01 | Delivery of document by public notice |
Addressee: Beijing Bencao Tianyuan Pharmaceutical Research Institute Document name: Notification to Pay the Fees |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Beijing Bencao Tianyuan Pharmaceutical Research Institute Document name: Notification to Pay the Fees |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Sun Dejie Document name: payment instructions |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Sun Dejie Document name: payment instructions |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Sun Dejie Document name: Notice of Termination of Patent Rights |
|
DD01 | Delivery of document by public notice | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121114 |